HDFC Mutual Fund
When comparing, both lines start at 100. Tradinity's reference for the category: a total-return index (dividends reinvested). The fund's declared benchmark (BSE Healthcare Index (TRI)) is not available to us as a series.
This is an IDCW (dividend) option: it pays cash out of its NAV, so returns computed from the NAV alone would understate what an investor earned. See the Growth option of the same plan for performance.
Computed from this fund's actual NAVs. A SIP buys at the first NAV of each month and is valued at the latest NAV. Past returns do not guarantee future ones.
Weights are % of the scheme's assets from the latest month-end disclosure available to Tradinity. Shown from the Direct plan of this fund, which holds the same portfolio. The feed carries weights only: no quantities or rupee values.
Valuation ratios are weighted over the holdings we can match to a company (harmonic mean for P/E) and are withheld when they cover under half the portfolio.
| Holding | Sector | Weight | 3M change | P/E |
|---|---|---|---|---|
| Divis Laboratories Ltd. | Healthcare | 9.54% | — | 83.0 |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 8.94% | — | 143.5 |
| Torrent Pharmaceuticals Ltd. | Healthcare | 4.08% | — | 77.7 |
| Max Healthcare Institute Limited | Healthcare | 4.06% | — | 124.3 |
| Lupin Ltd. | Healthcare | 4.04% | — | 13.2 |
| Cipla Ltd. | Healthcare | 3.94% | — | 35.1 |
| Aster DM Quality Care Limited | Healthcare | 3.84% | — | 205.8 |
| Neuland Laboratories Limited | Healthcare | 3.70% | — | 56.5 |
| Anthem Biosciences Limited | Healthcare | 3.48% | — | 76.6 |
| Acutaas Chemicals Limited | Healthcare | 3.24% | — | 64.3 |
| Ipca Laboratories Ltd. | Healthcare | 3.23% | — | 39.8 |
| Shilpa Medicare Ltd | Healthcare | 3.10% | — | 110.1 |
| Alkem Laboratories Ltd. | Healthcare | 3.06% | — | 29.1 |
| Global Health Limited | Healthcare | 2.85% | — | 74.4 |
| Rubicon Research Limited | Healthcare | 2.82% | — | 111.0 |
| Fortis Healthcare Limited | Healthcare | 2.37% | — | 255.5 |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 2.34% | — | 316.1 |
| Krishna Institute Of Medical Sciences Limited | Healthcare | 2.25% | — | 105.1 |
| Vijaya Diagnostic Centre Limited | Healthcare | 2.24% | — | 75.9 |
| Jupiter Life Line Hospitals Limited | Healthcare | 1.94% | — | 9.0 |
| Zydus Lifesciences Limited | Healthcare | 1.93% | — | 32.6 |
| Dr Reddys Laboratories Ltd. | Healthcare | 1.90% | — | 150.9 |
| Metropolis Healthcare Ltd. | Healthcare | 1.90% | — | 28.1 |
| TREPS - Tri-party Repo | — | 1.83% | — | — |
| Molbio Diagnostics Limited | Healthcare | 1.77% | — | — |
| Biocon Ltd. | Healthcare | 1.73% | — | 596.5 |
| Wockhardt Ltd. | Healthcare | 1.61% | — | 94.2 |
| Sai Life Sciences Limited | Healthcare | 1.60% | — | 89.9 |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 1.39% | — | 73.1 |
| Thyrocare Technologies Ltd. | Healthcare | 1.31% | — | 34.6 |
| SYMBIOTEC PHARMALAB LIMITED**** | Healthcare | 1.21% | — | — |
| Ajanta Pharma Limited | Healthcare | 1.18% | — | 43.2 |
| Gland Pharma Ltd. | Healthcare | 1.09% | — | 34.4 |
| CORONA REMEDIES LIMITED | Healthcare | 1.07% | — | 62.6 |
| Eris Lifesciences Ltd | Healthcare | 1.06% | — | 84.5 |
| Jubilant Pharmova Limited | Healthcare | 0.85% | — | 677.0 |
| BAJAJ HEALTHCARE LIMITED | Healthcare | 0.57% | — | 44.9 |
| Novartis India Ltd. | Healthcare | 0.47% | — | 49.7 |
| Laxmi Dental Limited | Healthcare | 0.38% | — | 59.2 |
| Cohance Lifesciences Limited | Healthcare | 0.34% | — | 96.3 |
Expense ratio by month: Oct 25 2.08% · Nov 25 2.09% · Dec 25 2.10% · Jan 26 2.11% · Feb 26 2.09% · Mar 26 2.10% · Apr 26 2.88% · May 26 2.22% · Jun 26 2.23% · Jul 26 2.19% · Aug 26 2.16% · Sep 26 2.11%
In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched out after 30 days from the date of allotment.
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund house: website · factsheets · monthly portfolio · annual report
Not available: Morningstar rating (proprietary). "NAV history from" is the first NAV we hold.
Returns are computed by Tradinity from each scheme's own published NAV, so they are net of the fund's expenses. Periods over one year are annualised (CAGR). Past performance does not indicate future returns. Only Growth-option schemes are ranked: an IDCW scheme pays cash out of its NAV, so its NAV understates what an investor earned.
